1. Home
  2. CDW vs TEVA Comparison

CDW vs TEVA Comparison

Compare CDW & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDW
  • TEVA
  • Stock Information
  • Founded
  • CDW 1984
  • TEVA 1901
  • Country
  • CDW United States
  • TEVA Israel
  • Employees
  • CDW N/A
  • TEVA N/A
  • Industry
  • CDW Catalog/Specialty Distribution
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDW Consumer Discretionary
  • TEVA Health Care
  • Exchange
  • CDW Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • CDW 23.7B
  • TEVA 19.2B
  • IPO Year
  • CDW 1993
  • TEVA N/A
  • Fundamental
  • Price
  • CDW $177.63
  • TEVA $16.44
  • Analyst Decision
  • CDW Buy
  • TEVA Strong Buy
  • Analyst Count
  • CDW 8
  • TEVA 8
  • Target Price
  • CDW $244.63
  • TEVA $19.63
  • AVG Volume (30 Days)
  • CDW 1.5M
  • TEVA 7.0M
  • Earning Date
  • CDW 10-30-2024
  • TEVA 11-06-2024
  • Dividend Yield
  • CDW 1.41%
  • TEVA N/A
  • EPS Growth
  • CDW 2.13
  • TEVA N/A
  • EPS
  • CDW 8.18
  • TEVA N/A
  • Revenue
  • CDW $20,831,200,000.00
  • TEVA $16,772,000,000.00
  • Revenue This Year
  • CDW N/A
  • TEVA $4.70
  • Revenue Next Year
  • CDW $2.80
  • TEVA $4.47
  • P/E Ratio
  • CDW $21.71
  • TEVA N/A
  • Revenue Growth
  • CDW N/A
  • TEVA 9.81
  • 52 Week Low
  • CDW $175.94
  • TEVA $8.83
  • 52 Week High
  • CDW $263.37
  • TEVA $19.31
  • Technical
  • Relative Strength Index (RSI)
  • CDW 25.60
  • TEVA 32.20
  • Support Level
  • CDW $187.73
  • TEVA $17.07
  • Resistance Level
  • CDW $204.76
  • TEVA $17.51
  • Average True Range (ATR)
  • CDW 5.48
  • TEVA 0.50
  • MACD
  • CDW -1.95
  • TEVA -0.20
  • Stochastic Oscillator
  • CDW 3.72
  • TEVA 8.89

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology ("IT") solutions to small, medium, and large business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. The company has three operating segments namely, Corporate, Small Business, and Public. The Corporate segment generates the majority of its revenue and primarily serves US private sector business customers with more than 250 employees.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: